Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure

Fan Dong; Tianyuan Xu; Yifan Shen; Shan Zhong; Shanwen Chen; Qiang Ding; Zhoujun Shen

doi:10.18632/oncotarget.15173

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure

Fan Dong, Tianyuan Xu, Yifan Shen, Shan Zhong, Shanwen Chen, Qiang Ding and Zhoujun Shen _

PDF | HTML | How to cite

Oncotarget. 2017; 8:27547-27568. https://doi.org/10.18632/oncotarget.15173

Metrics: PDF 2232 views | HTML 4790 views | ?

Abstract

Fan Dong1, Tianyuan Xu2, Yifan Shen1, Shan Zhong1, Shanwen Chen1, Qiang Ding1 and Zhoujun Shen1

1 Department of Urology, Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China

2 Department of Urology, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China

Correspondence to:

Zhoujun Shen, email:

Keywords: microRNA, bladder cancer, expression profile, biogenesis procedure

Received: October 19, 2016 Accepted: January 24, 2017 Published: February 07, 2017

Abstract

Aberrant expression profiles of miRNAs are widely observed in the clinical tissue specimens and urine samples as well as the blood samples of bladder cancer patients. These profiles are closely related to the pathological features of bladder cancer, such as the tumour stage/grade, metastasis, recurrence and chemo-sensitivity. MiRNA biogenesis forms the basis of miRNA expression and function, and its dysregulation has been shown to be essential for variations in miRNA expression profiles as well as tumourigenesis and cancer progression. In this review, we summarize the up-to-date and widely reported miRNAs in bladder cancer that display significantly altered expression. We then compare the miRNA expression profiles among three different sample types (tissue, urine and blood) from patients with bladder cancer. Moreover, for the first time, we outline the dysregulated miRNA biogenesis network in bladder cancer from different levels and analyse its possible relationship with aberrant miRNA expression and the pathological characteristics of the disease.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15173

Publication Alerts

Reviews:

Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure

Abstract